Skip to content

Investigating the analgesic effect of Foeniculum vulgare essential oil phytosome

Preparation of phytosome containing Foeniculum vulgare essential oil and its evaluation in reducing the pain intensity of primary dysmenorrhoea patients

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100420003760N6
Enrollment
36
Registered
2023-03-29
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: group receiving a low dose of phytosome made containing anethole and mefenamic acid. Intervention 2: Intervention group: the group receiving a moderate dose of phyt

Sponsors

Khoram-Abad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Women with regular menstrual cycles with primary dysmenorrhea whose body mass index is also determined (less than or greater than 25).

Exclusion criteria

Exclusion criteria: Use of birth control pills Use of pain relievers Using pain relief methods such as acupressure Suffering from certain diseases Having an allergy to non-steroidal anti-inflammatory drugs and fennel

Design outcomes

Primary

MeasureTime frame
Pain level is measured by two methods of interview and VAS questionnaire (0-10) at the beginning and end of each cycle during 3 consecutive cycles. Timepoint: Pain intensity between three consecutive cycles (12 weeks) in different experimental groups. Method of measurement: Pain level is measured by two methods of interview and VAS questionnaire (0-10).

Secondary

MeasureTime frame
Pain level is measured by two methods of interview and VAS questionnaire (0-10) at the beginning and end of each cycle during 3 consecutive cycles. Timepoint: Pain level is measured by two methods of interview and VAS questionnaire (0-10) at the beginning and end of each cycle during 3 consecutive cycles. Method of measurement: Pain intensity between three consecutive cycles (12 weeks) in different experimental groups.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMarzieh Rashidipour

Khoram-Abad University of Medical Sciences

m_rashidi80@yahoo.com+98 66 3312 0172

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026